Universal antiretroviral therapy (ART) for all pregnant/ breastfeeding women living with HIV, known as prevention of mother-to-child transmission of HIV (PMTCT) Option B+ (PMTCTB+), is being scaled up in most countries in Sub-Saharan Africa.
Swaziland has one of the highest adult HIV prevalence rates worldwide, 27%; with approximately 200,000 people 15 years and older living with HIV. Swaziland and many other countries in sub-Saharan Africa have adopted universal test-and-treat (UTT) policies.
Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are partners in continuing the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program in Swaziland.
Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are partners in continuing the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program in Swaziland.
Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are partners in continuing the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program in Swaziland.
Through the TSP Program, Baylor-Swaziland and Baylor-Malawi are partners in continuing the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program in Swaziland.
Overall responsibilities:
New research marks welcome step to make trans women in sub-Saharan Africa visible in HIV data
Applications are sought from experienced, mission-driven candidates who meet the following profile:
Baylor-Malawi is seeking a consultant experienced in the areas of pharmacy systems strengthening and pharmaceutical supply chain management to support the transition of the SIAPS (Systems for Improved Access to Pharmaceuticals and Services) program in Swaziland from Management Sciences for Health
